key: cord-0739831-xi71dcb0
authors: Finsterer, J.
title: Steroid-responsive, transverse myelitis is a known complication of COVID-19
date: 2021-03-31
journal: J Neuroimmunol
DOI: 10.1016/j.jneuroim.2021.577566
sha: f4bb2438e8d3d62d2a19c2bc92b684b07d295ba6
doc_id: 739831
cord_uid: xi71dcb0

nan

myelitis and beneficial response to steroids were listed in table-1 of the paper [1] .

The time course of the various medical events is not clearly traceable. The patient visited his primary care clinic "a few weeks ago" for headache, nausea, and low-grade fever [1] . There the patient was tested positive for SARS-CoV-2 and self-quarantined [1] . During quarantine he developed fatigue, myalgia, and low-grade fever, and urinary hesitancy requiring disposable catheterisation [1] . We should know if fever prior to quarantine persisted until and during quarantine or if fever during quarantine newly developed. We also should know what is meant with "after his diagnosis". If the authors mean COVID-19 the patient developed urinary retention already during quarantine,

There is a discrepancy between symptoms and signs. The patient reported, amongst others, sensory disturbances of his right face and right upper limb but the clinical neurologic exam did not reveal any facial or right upper limb sensory disturbance [1] . We should be told how to explain this discrepancy.

An explanation is also required for right facial and limb upper limb sensory disturbance in the absence of a cerebral lesion on MRI. Pleocytosis alone does not explain these symptoms. We should know which types of MRI modalities

Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature

Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia

Acute transverse myelitis attributed to SARS-CoV-2 infection presenting as impaired mobility: a case report

Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement

Acute disseminated encephalomyelitis in a COVID-19 pediatric patient